Breakthru Medicine

Developing Big Weapons For The War Against Cancer

About this Event

Breakthru Medicine is developing precision cancer therapies, with their first small molecule entering the clinic in early 2027, targeting this $18B+ solid cancer market with massive unmet need. The preclinical animal data demonstrates an industry leading efficacy across multiple major cancer indications with this novel mechanism of action.

The company is also developing two platform technologies with two high-value modalities—antibody drug conjugates with differentiated, novel payloads and molecular glues to drug targets deemed ‘undruggable’ by conventional methods. These novel approaches have the potential to extend hundreds of thousands of lives across pancreatic, breast, prostate, colorectal and lung cancers.

Register now to watch this online event with Breakthru Medicine CEO, Steve Potts, to learn more about their therapies and the team behind them, which has collectively delivered more than 12 FDA-approved drugs and dozens of successful INDs.

Video On Demand

– Recorded

November 13

SHARE THIS EVENT

All statements and expressions are the sole opinion of the company and are subject to change without notice. The Company is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial advisor, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. Information contained herein contains “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities and Exchange Act of 1934, as amended. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be “forward looking statements”. Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of words such as “expects”, “will”, “anticipates”, “estimates”, “believes”, or by statements indicating certain actions “may”, “could”, “should” or “might” occur.